Inogen Inc (INGN): Brenton Taylor , EVP, Engineering of Inogen Inc sold 6,500 shares on Apr 13, 2016. The Insider selling transaction was reported by the company on Apr 14, 2016 to the Securities and Exchange Commission. The shares were sold at $48.00 per share for a total value of $312,000.00 according the SEC Form 4 Filing.
Company has been under the radar of several Street Analysts.Inogen Inc is Initiated by Piper Jaffray to Neutral. The Rating was issued on Mar 24, 2016.Inogen Inc is Reiterated by Needham to Strong Buy while Lowering the Price Target of the company shares to $ 45 from a previous price target of $55 . The Rating was issued on Feb 12, 2016.
Currently the company Insiders own 5.31% of Inogen Inc shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by -7.12%.Institutional Investors own 97.97% of Inogen Inc shares.During last six month period, the net percent change held by insiders has seen a change of -14.83%.
Shares of Inogen Inc (INGN) ended Monday, Apr 11, 2016 session in red amid volatile trading. The shares closed down -0.82 points or -1.75% at $45.98 with 1,79,200 shares getting traded. Post opening the session at $46.81, the shares hit an intraday low of $45.6501 and an intraday high of $47.2647 and the price vacillated in this range throughout the day. The company has a market cap of $913 M and the number of outstanding shares has been calculated to be 1,98,52,800 shares. The 52-week high of Inogen Inc is $55.98 and the 52-week low is $28.814.
Inogen Inc. is a medical technology company. The Company is engaged in developing manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company offers Inogen One systems such as Inogen One G3 and G2 that concentrate the air around the patients to offer a single source of supplemental oxygen. The Inogen One G3 and G2 have up to 4.5 and five hours of battery life respectively. The Company’s Inogen One G2 is effective for nocturnal use.